Hap Trading, LLC Heron Therapeutics, Inc. Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	BUY	$10.23 - $24.56 $400,146 - $960,664	39,115 New	39,115 $459,000
Q4 2019 Feb 11, 2020	SELL	$17.42 - $26.61 $239,734 - $366,206	-13,762 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$16.36 - $21.39 $111,248 - $145,452	-6,800 Reduced 33.07%	13,762 $255,000
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $291,111 - $450,852	-17,195 Reduced 45.54%	20,562 $382,000
Q3 2018 Nov 09, 2018	BUY	$30.0 - $40.85 $615,510 - $838,119	20,517 Added 119.01%	37,757 $1.2 Million
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $455,136 - $724,080	17,240 New	17,240 $670,000

174

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $220M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.